Who backs Solve Therapeutics?
16 investors| Investor | Type |
|---|---|
| University of California | Other |
| Alexandria Venture Investments | Other |
| General Atlantic | Growth equity |
| Ally Bridge Group | Growth equity |
| Surveyor Capital | Hedge fund |
| Balyasny Asset Management | Hedge fund |
| B Capital | Family office |
| Matrix Capital Management | Hedge fund |
| Abingworth | — |
| AyurMaya Capital | — |
| + 6 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Solve Therapeutics investors
16 investors are on record for Solve Therapeutics, including University of California, Alexandria Venture Investments, General Atlantic and Ally Bridge Group. By type, the record holds 3 hedge funds and 2 growth equity firms. The early-stage round in Nov 2025 drew 16 investors.
Free account
More of Solve Therapeutics with a free account
- ·The complete investor list: 16 names
- ·Watch Solve Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 16 firms already write checks for companies like Solve Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View